(Q28297154)

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3368123

2 January 2023

E. Wertman

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3368123

2 January 2023

D. M. Michaelson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3368123

full work available at URL

2 January 2023

language of work or name

English

0 references

publication date

31 March 1988

0 references

https://api.elsevier.com/content/article/PII:0304394088905770?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

https://api.elsevier.com/content/article/PII:0304394088905770?httpAccept=text/plain

2 January 2023

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

2 January 2023

0 references

86

0 references

issue

2

0 references

page(s)

235-40

0 references

cites work

Effects of ganglioside treatment in rats with a lesion of the cholinergic forebrain nuclei.

1

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

2 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tangles

2 January 2023

6

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

Recovery of cortical acetylcholine output after ganglioside treatment in rats with lesion of the nucleus basalis

2 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease

2 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

Abnormal maturation of cerebral cortex and behavioral deficit in adult rats after neonatal administration of antibodies to ganglioside.

2 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

Editorial: The prevalence and malignancy of Alzheimer disease. A major killer

2 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

2 January 2023

14

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

The neuropathology of Alzheimer's disease: a review with pathogenetic, aetiological and therapeutic considerations

2 January 2023

15

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

Dementia and Parkinson's disease--pathological and neurochemical considerations

2 January 2023

16

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

Biological activities of antibodies injected into the brain

2 January 2023

17

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

Identification of a cholinergic-specific antigen Chol-1 as a ganglioside

2 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

Antibodies to gangliosides inhibit goldfish optic nerve regeneration in vivo

2 January 2023

19

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

The stimulating effect of ganglioside injections on the recovery of choline acetyltransferase and acetylcholinesterase activities in the hippocampus of the rat after septal lesions

2 January 2023

20

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90577-0

2 January 2023

Identifiers

0 references